These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28592035)

  • 1. [Evaluate the role of the guidelines from the development of "Chinese guidelines for the diagnosis and treatment of invasive fungal disease in patients with hematological disorders and cancers" in China].
    Huang XJ
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):393-394. PubMed ID: 28592035
    [No Abstract]   [Full Text] [Related]  

  • 2. [Undefined invasive fungal disease: a perspectie from the Chinese guidelines for the diagnosis and treatment of invasive fungal disease in patients with hematological disorders and cancers].
    Hu J
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):395-397. PubMed ID: 28592036
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnostic criteria and therapeutic principle of invasive fungal infection in hematological diseases or malignant tumors].
    Shen ZX
    Zhonghua Nei Ke Za Zhi; 2007 Jul; 46(7):532-3. PubMed ID: 17959068
    [No Abstract]   [Full Text] [Related]  

  • 4. [The Chinese guidelines for the diagnosis and treatment of invasive fungal disease in patients with hematological disorders and cancers (the fifth revision)].
    Chinese Invasive Fungal Infection Working Group
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):453-459. PubMed ID: 28592049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Advances in diagnosis of hematological disorders.
    Choudhry VP
    Indian J Pediatr; 2013 Sep; 80(9):754-5. PubMed ID: 23943572
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rheumatic and hemato-/oncological disorders].
    Reuss-Borst MA
    Z Rheumatol; 2005 Feb; 64(1):3-11. PubMed ID: 15756494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometry in hematological disorders.
    Pati HP; Jain S
    Indian J Pediatr; 2013 Sep; 80(9):772-8. PubMed ID: 23943573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hematology 2008].
    Borchmann P; Eichhorst B; Hellmann M; Hübel K; Kochanek M; Kreuzer KA; Reiser M; Hallek M
    Dtsch Med Wochenschr; 2008 Jun; 133(25-26):1400-4. PubMed ID: 18553270
    [No Abstract]   [Full Text] [Related]  

  • 9. Update in hematology and medical oncology: evidence published in 2011.
    Kahn MJ; Ma AD; Shulman LN
    Ann Intern Med; 2012 Aug; 157(4):276-83. PubMed ID: 22910938
    [No Abstract]   [Full Text] [Related]  

  • 10. ["Current Issues in Hematology 2002" continuing education course--review and prospects for the future].
    Demeter J
    Magy Onkol; 2003; 47(2):221-2. PubMed ID: 14655687
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hematology 2010].
    Dreyling M; Subklewe M; Braess J; Spiekermann K
    Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1322-5. PubMed ID: 20556691
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent developments in the management of invasive fungal infections in patients with hematological malignancies.
    Karthaus M; Cornely OA
    Ann Hematol; 2005 Apr; 84(4):207-16. PubMed ID: 15614521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment recommendations for invasive fungal disease in pediatric patients with cancer or blood disease].
    Tang S; ; ; ;
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):426-9. PubMed ID: 25190161
    [No Abstract]   [Full Text] [Related]  

  • 14. Reflections on 45 years as a clinical hematologist.
    Boxer M
    Clin Adv Hematol Oncol; 2020 Mar; 18(3):160-161. PubMed ID: 32609665
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oncological and hematological emergencies: intensive care management].
    Hallek M; von Bergwelt-Baildon M
    Internist (Berl); 2013 Sep; 54(9):1041-2. PubMed ID: 23989316
    [No Abstract]   [Full Text] [Related]  

  • 16. Hematology/Oncology Emergencies.
    Perkins JC; Davis JE
    Hematol Oncol Clin North Am; 2017 Dec; 31(6):xiii-xiv. PubMed ID: 29078935
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014.
    Slavin MA; Thursky KA; Worth LJ; Chang CC; Morrissey CO; Blyth CC; Chen SC; Szer J
    Intern Med J; 2014 Dec; 44(12b):1267-76. PubMed ID: 25482739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Cornely OA; Böhme A; Buchheidt D; Glasmacher A; Kahl C; Karthaus M; Kern W; Krüger W; Maschmeyer G; Ritter J; Salwender HJ; Sandherr M; Schiel X; Schüttrumpf S; Sieniawski M; Silling G; Ullmann AJ; Wolf HH;
    Ann Hematol; 2003 Oct; 82 Suppl 2():S186-200. PubMed ID: 13680164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan.
    Kobayashi R; Kaneda M; Sato T; Ichikawa M; Suzuki D; Ariga T
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):886-90. PubMed ID: 19131772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergencies in Hematology and Oncology.
    Halfdanarson TR; Hogan WJ; Madsen BE
    Mayo Clin Proc; 2017 Apr; 92(4):609-641. PubMed ID: 28385197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.